Category: Press Releases

Xavier Morge is appointed CEO of BIOASTER

Xavier Morge took up his new position on November 30th and replaces Nathalie Garçon as BIOASTER’s CEO. As per her own request, Nathalie Garçon, previously CEO and CSO, will now...

We formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology

BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology

FIND and BIOASTER collaborate on clinical research

FIND and BIOASTER collaborate on clinical research to assess duration of immune response in patients with COVID-19

EVOTEC & BIOASTER partner to build a technology and innovation hub in Lyon

New collaboration Gustave Roussy – IRT BIOASTER

«Fishing for success: Cancer microbiome-targeted culturomics to extract the most immunogenic commensals»

Mologic and Institut Pasteur de Dakar launch accelerated programme to develop rapid diagnostic test for Ebola

Project aims to facilitate early diagnosis and support efforts to stop the Ebola Virus Disease epidemic

Launch of EU Research Project ImmunoSep: Advancing Personalised Immunotherapy in Sepsis

Multinational consortium aims to identify novel biomarkers, and therapeutic targets needed for future precis ion medicine approaches

BioFilm Pharma and BIOASTER collaborate to accelerate the emergence of a new class of drugs to fight antibiotic resistance and chronic infections

A new collaboration with Kaleido & MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome

Kaleido Biosciences to collaborate with BIOASTER and MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome.   Kaleido Biosciences, a U.S.-based clinical-stage healthcare company,...